Drawing for BIOMATRIX

USPTO serial 90004719

BIOMATRIX

Reviewed by CopyMark Law Group

Reg. 6244576Status 702Renewal
Filing date
Status date
Registration date
Jan 12, 2021
Examiner
GOLD, BARBARA
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with BIOMATRIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gina L. Durham, Esq.

Gina L. Durham, Esq. DLA PIPER LLP (US)555 MISSION STREET, SUITE 2400SAN FRANCISCO, CA 94105-0922United States

Goods and services

ClassDescriptionStatusFirst use
035Retail pharmacy services; specialty retail pharmacy services; Health care utilization and review services as they relate to prescription drugs, namely, pharmaceutical cost management and drug review utilization services, verification of benefits, prior authorization and review services and coordination of delivery and access to prescription drugs; Specialty pharmacy services, namely, retail pharmaceutical distributorship services in the field of special purpose infusion-based, injectable and oral pharmaceuticals; Business administration of pharmacy reimbursement programs and services in the field of specialty pharmaceuticals for health benefit plan subscribers; Pharmaceutical cost management services and drug utilization review services for patients with complex or chronic medical conditions, all of the foregoing not including dietary supplements or nutraceuticalsACTIVEJul 17, 2015
044Medical services, namely, providing home infusion services, specialty infusion services, ambulatory infusion services, and specialty pharmacy services in the nature of pharmaceutical advice and dispensing of pharmaceuticals; providing in-home and ambulatory dispensing and administering of infusion pharmaceuticals and nutritional therapy services; providing consultation in the dispensing of pharmaceuticals and pharmaceutical advice; Skilled nursing services in the nature of medication assistance and infusion services; home-visit nursing care; Providing medical information regarding prescription drugs and drug therapy; providing medical information regarding patients' prescription drugs and drug therapy; developing and managing comprehensive programs comprising medical drug therapy and physician support services in the nature of providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues; healthcare services in the nature of providing and administering infusion biologics therapies for transplant, immunology, neurology and hematology; healthcare services in the nature of immunization services; medical evaluation services, namely, disease management programs; healthcare assessment services in the field of patient treatment protocols and patient outcomes, all of the foregoing not including dietary supplements or nutraceuticalsACTIVEJul 17, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 28, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Apr 28, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 28, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 3, 2026E815TEAS SECTION 8 & 15 RECEIVED
Jan 12, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 12, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 27, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 27, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 7, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 19, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2020XAECEXAMINER'S AMENDMENT ENTERED
Sep 18, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 18, 2020GNEAEXAMINERS AMENDMENT E-MAILED
Sep 18, 2020CNEAEXAMINERS AMENDMENT -WRITTEN
Sep 18, 2020DOCKASSIGNED TO EXAMINER
Jul 15, 2020MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 14, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 19, 2020NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance